Home4151 • TYO
Kyowa Kirin Co Ltd
add
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (JPY) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 132.76B | -2.51% |
Operating expense | 74.83B | 15.66% |
Net income | 3.97B | -85.64% |
Net profit margin | 2.99 | -85.26% |
Earnings per share | — | — |
EBITDA | 25.31B | -35.09% |
Effective tax rate | 66.59% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (JPY) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 244.68B | -39.59% |
Total assets | 1.07T | 4.04% |
Total liabilities | 216.55B | 14.26% |
Total equity | 850.81B | — |
Shares outstanding | 523.36M | — |
Price to book | 1.36 | — |
Return on assets | 4.58% | — |
Return on capital | 5.67% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (JPY) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | 3.97B | -85.64% |
Cash from operations | -1.71B | -105.46% |
Cash from investing | -46.57B | -490.41% |
Cash from financing | -1.03B | 9.75% |
Net change in cash | -51.65B | -348.12% |
Free cash flow | -47.48B | -784.19% |
Previous close
¥2,204.00
Day range
¥2,190.00 - ¥2,212.00
Year range
¥2,025.00 - ¥3,350.00
Market cap
1.16T JPY
Avg Volume
1.28M
P/E ratio
19.50
Dividend yield
2.63%
Primary exchange
TYO
About
Kyowa Kirin Co., Ltd. is a Japanese pharmaceutical and biotechnology company under the Kirin Holdings, and is among the 40 largest in the world by revenue. The company is headquartered in Chiyoda-ku, Tokyo and is a member of the Nikkei 225 stock index. Wikipedia
Founded
Jul 1, 1949
Website
Employees
5,669
